Khazanah Nasional Berhad has filed a 13F-HR report, detailing its investment holdings valued at approximately $142.96 million as of March 31, 2022. This update is significant as it provides insights into the company's investment strategies and positions in various securities.
Khazanah Nasional Berhad, identified by its Central Index Key (CIK) 0001763068, is an investment management entity based in Kuala Lumpur, Malaysia. The company operates outside the U.S. and does not have publicly listed tickers or exchanges. Its recent filings include multiple 13F-HR forms submitted on October 20, 2026, which reflect its ongoing investment activities.
The filing indicates that Khazanah holds a total of four positions, with a significant investment in the iShares Core MSCI Europe ETF, valued at approximately $88.67 million. Other notable holdings include the iShares Core S&P 500 ETF, Rapid Micro Biosystems Inc., and Sea Ltd, showcasing a diverse investment portfolio. The Chief Investment Officer, Mohamad Hishammudin bin Hamdan, signed the report, emphasizing the company's commitment to transparency.
This filing may impact various stakeholders, including investors and analysts who track investment management trends. The disclosed holdings provide a snapshot of Khazanah's investment approach, which may influence competitors and the broader market. The filing does not specify what actions will follow this disclosure, leaving stakeholders to analyze the implications of these investments.
Details were not available in the SEC filing regarding future actions or plans following this report.